Comparative Study
doi: 10.1517/14656566.6.1.1.
Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'
- PMID: 15709877
- DOI: 10.1517/14656566.6.1.1
Item in Clipboard
Comparative Study
Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'
Expert Opin Pharmacother.
2005 Jan.
No abstract available
Comment on
-
Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.Expert Opin Pharmacother. 2005 Jan;6(1):75-84. doi: 10.1517/14656566.6.1.75. Expert Opin Pharmacother. 2005. PMID: 15709885 Review.
Similar articles
-
New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.J R Soc Promot Health. 2003 Jun;123(2):79-80. doi: 10.1177/146642400312300209. J R Soc Promot Health. 2003. PMID: 12852189 No abstract available.
-
Phosphodiesterase-5 inhibitors: clinical market and basic science comparative studies.Curr Urol Rep. 2004 Dec;5(6):451-9. doi: 10.1007/s11934-004-0070-2. Curr Urol Rep. 2004. PMID: 15541215 Review.
-
Phosphodiesterase 5 inhibitors for erectile dysfunction.Ann Pharmacother. 2005 Jul-Aug;39(7-8):1286-95. doi: 10.1345/aph.1E487. Epub 2005 Jun 7. Ann Pharmacother. 2005. PMID: 15941818 Review.
-
Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.World J Urol. 2005 Dec;23(6):374-84. doi: 10.1007/s00345-005-0022-6. Epub 2005 Nov 5. World J Urol. 2005. PMID: 16273417 Review.
-
Phosphodiesterase 5 inhibitors in male sexual dysfunction.Curr Opin Urol. 2003 Sep;13(5):405-10. doi: 10.1097/00042307-200309000-00008. Curr Opin Urol. 2003. PMID: 12917517 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
